Bicocca Open Archive

Logo unimib boa
MANTOVANI, LORENZO GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.612
EU - Europa 9.562
AS - Asia 2.821
SA - Sud America 55
Continente sconosciuto - Info sul continente non disponibili 37
AF - Africa 34
OC - Oceania 27
Totale 32.148
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.331
IT - Italia 2.614
DE - Germania 1.570
IE - Irlanda 1.519
CN - Cina 1.426
SE - Svezia 1.371
HK - Hong Kong 808
UA - Ucraina 670
GB - Regno Unito 514
RU - Federazione Russa 285
CA - Canada 271
FI - Finlandia 208
FR - Francia 192
DK - Danimarca 180
AT - Austria 171
VN - Vietnam 153
IN - India 145
TR - Turchia 106
NL - Olanda 63
IR - Iran 43
BE - Belgio 42
BR - Brasile 33
EU - Europa 30
CH - Svizzera 28
ES - Italia 27
KR - Corea 22
RO - Romania 20
PL - Polonia 19
AU - Australia 17
PK - Pakistan 17
JP - Giappone 16
SG - Singapore 13
CZ - Repubblica Ceca 12
NG - Nigeria 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
NZ - Nuova Zelanda 10
GR - Grecia 9
ID - Indonesia 9
OM - Oman 9
BG - Bulgaria 8
CL - Cile 8
MX - Messico 8
EG - Egitto 7
NO - Norvegia 7
BD - Bangladesh 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AR - Argentina 5
CO - Colombia 4
ET - Etiopia 4
HR - Croazia 4
IQ - Iraq 4
MD - Moldavia 4
MK - Macedonia 4
PT - Portogallo 4
RS - Serbia 4
LK - Sri Lanka 3
LV - Lettonia 3
SC - Seychelles 3
ZA - Sudafrica 3
A1 - Anonimo 2
BO - Bolivia 2
GE - Georgia 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CU - Cuba 1
DZ - Algeria 1
EC - Ecuador 1
GH - Ghana 1
HN - Honduras 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
LI - Liechtenstein 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NP - Nepal 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 32.148
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.737
Fairfield 1.958
Woodbridge 1.677
Chandler 1.434
Dublin 1.414
Houston 1.203
Wilmington 1.164
Frankfurt am Main 1.127
Ashburn 1.092
Seattle 839
Hong Kong 795
Jacksonville 732
New York 709
Princeton 664
Cambridge 662
Dearborn 640
Milan 628
Altamura 302
Lawrence 292
Nanjing 261
Vienna 165
San Diego 153
Beijing 127
Hangzhou 126
Lachine 104
Andover 100
Dong Ket 100
Shenyang 94
Nanchang 92
Shanghai 88
London 87
Rome 87
Saint Petersburg 87
Toronto 77
Guangzhou 76
Fremont 75
Helsinki 73
Hebei 70
Boardman 66
Jinan 65
Menlo Park 63
Tianjin 62
Norwalk 59
Jiaxing 56
Falls Church 53
Changsha 48
Ottawa 45
Redmond 44
Ningbo 42
Zhengzhou 39
Lissone 35
Washington 35
Brussels 32
Los Angeles 32
Bologna 29
Pune 28
Taizhou 28
Hefei 27
Lappeenranta 26
Moscow 26
Perugia 26
Kunming 23
Mountain View 22
Monza 21
Verona 21
Bonndorf 19
Palermo 18
Chicago 16
Huizen 16
Parma 16
Edmonton 15
Napoli 15
Boston 14
Genoa 14
Kocaeli 14
Legnano 14
Nürnberg 14
Bergamo 13
Duncan 13
Kazan 13
São Paulo 13
Carate Brianza 12
Collegeville 12
Florence 12
Phoenix 12
San Mateo 12
Trieste 12
Turin 12
Hyderabad 11
Kilburn 11
Buffalo 10
Hounslow 10
Leawood 10
Montréal 10
Casale sul Sile 9
Fuzhou 9
Giussano 9
Haikou 9
Paris 9
Auckland 8
Totale 24.600
Salva come PNG Salva come JPEG
Nome #
Costi dell’infarto miocardico acuto: analisi di dati sanitari amministrativi 650
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry 364
Administrative databases as a tool for identifying healthcare demand and costs in an over-one million population 334
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study 300
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 283
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors 278
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 277
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review 258
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 229
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 224
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study) 221
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 212
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 212
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 209
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 203
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 186
Treatment of venous thromboembolism with tinzaparin in oncological patients 186
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 185
Global, regional, and national burden of suicide mortality 1990 to 2016: Systematic analysis for the Global Burden of Disease Study 2016 185
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 185
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 182
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 180
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry 177
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 175
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 171
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 170
Health Related Quality of Life in the Major Liver Conditions 169
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity 169
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 168
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 167
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 166
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 164
Cost-Effectiveness and Cost-Utility Analysis of Spinal Cord Stimulation in Patients With Failed Back Surgery Syndrome: Results From the PRECISE Study 164
Health related quality of life in chronic liver diseases 163
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 162
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 161
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 160
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 159
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 159
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 159
The impact of liver disease on the health-related quality of life 159
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 157
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 157
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis 157
Medical Costs And Resources Consumption In Patients With Atrial Fibrillation: An Italian Observational Study 157
Estimates of the initial impact of the COVID-19 epidemic on overall mortality: evidence from Italy 156
Economic Burden of Urticaria Requiring Hospitalization: Analysis from an Administrative Database 155
Sustainability of the Italian National Health Service 155
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases 154
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context 154
Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 152
Il burden delle polmoniti: analisi dai database amministrativi (DENALI) della regione Lombardia. 151
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 149
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 148
Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 148
Benefits in pain perception, ability function and health-related quality of life in patients with failed back surgery syndrome undergoing spinal cord stimulation in a clinical practice setting 148
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 147
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 147
Persistence and adherence to hypolipemic therapy in real practice: Results of a large administrative database 146
Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: Barriers to and strategies for optimal implementation 146
The Burden of Severe Hypoglicaemias and Diabetes Ketoacidosis: A Population-Based Study 145
Economic Burden Of Stroke: Analysis From An Administrative Database 144
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 143
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: Co-medication interactions 143
Impatto clinico ed economico della gestione dei rialzi pressori in gravidanza in regime di pronto soccorso: il possibile ruolo dei marcatori biochimici 143
Costs and effectiveness of influenza vaccination: A systematic review 142
Implantable Cardioverter Defibrillator in Italy from 2000 to 2008: a population-based analysis using health administrative databases. 141
New pharmacoeconomic option in uremic anemia management [3] 141
The socioeconomic burden of patients affected by hemophilia with inhibitors 141
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 141
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation 139
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 138
XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America 137
Cost and outcomes after first acute myocardial infarction: study on 12049 individuals using administrative databases 135
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 135
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 133
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 133
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 133
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 132
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 132
Resource utilization and costs for patients with inflammatory bowel diseases in italy: a population-based assessment 131
Cost-effectiveness analysis of pharmacokinetic-driven prophylaxis vs. standard prophylaxis in patients with severe haemophilia A 130
Economic burden of pneumoniae requiring hospitalization in italy: analysis from an administrative database 129
Epidemiology and Direct Health Care Costs of Diabetic Retinopathy: Results From a Population-Based Study 128
The Cost Of Illness Of Atrial Fibrillation In Italy: A Cohort Of Hospitalized Patients 128
Implantable cardioverter defibrillator (ICD) in Italy from 2000 to 2008: a population-based analysis using health administrative databases 127
Immune tolerance induction in patients with haemophilia a and inhibitors: Effectiveness and cost analysis in an European Cohort (The ITER Study) 127
The Economic Impact of The use of Implantable Cardioverter Defibrillator In Primary Prevention 126
Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation 126
The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities 125
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 124
Utilization of disease modifying agents in multiple sclerosis: from an Italian administrative database. 123
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases 123
Use of implantable cardioverter defibrillator therapy in Lombardy from 2005 to 2010 122
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 121
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 120
Inflammatory bowel diseases in italy: incidence trends and patients’ characteristics 119
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 118
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 117
The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients 116
Totale 16.820
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.286 0 0 0 0 0 0 0 0 0 0 504 782
2019/20205.519 661 265 364 481 486 724 730 495 552 323 318 120
2020/20216.836 668 445 713 524 590 615 699 682 567 512 363 458
2021/20223.998 321 391 400 360 275 301 196 248 234 295 280 697
2022/20236.452 781 1.874 537 518 456 979 74 355 480 93 182 123
2023/20244.596 171 247 185 271 683 1.300 860 191 518 154 16 0
Totale 34.167